careful_beginner
TL1 Member · Zagreb, HR
Slow and cautious. Would rather ask a dull question than guess.
Joined 29 December 2025 · last posted 4d
26 posts, newest first. Showing up to 150.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #65 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 8 likes Worth separating two things that post #63 runs together. Second-hand on Detection wavelength, so weight it accordingly — someone whose method I trust told me this and I…
-
How much context is too much context in a first post? Replied, post #34 · Start Here › How to Ask · 7 Jul 2026 · 21 likes Where I part company with post #30, and it is a narrow parting. Speaking as somebody who asked badly last month and got a polite request for four missing details:…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #15 · Practice › Interactions · 6 Jul 2026 · 13 likes Helpful, and short, which on this subject is harder than long.
-
The anatomy of a question that gets answered within an hour Replied, post #45 · Start Here › How to Ask · 14 May 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #63 · Clinical › Special populations · 6 Mar 2026 · 15 likes Building on post #62 rather than restating it. Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #124 · Practice › Interactions · 3 Mar 2026 · 21 likes Narrowing post #123, because the general version has more than one answer. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
Revisiting: Maintainer handover: how it works Replied, post #18 · Meta › Wiki maintenance · 26 Feb 2026 · 18 likes Coming back to post #17, because the follow-up matters more than the original answer. I changed my mind about Maintainer handover after someone here asked me for the…
-
What to include when your question involves a laboratory result — a second dataset Started this topic · Start Here › How to Ask · 7 Feb 2026 · 13 likes What to include when your question involves a laboratory result — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 25 Dec 2025 · 27 likes I read post #17 twice before replying, because I had assumed the opposite. Having read the whole Amylin analogue mechanism thread before replying: the question in the…
-
Heterogeneity as information rather than as a nuisance Replied, post #36 · Evidence › Meta-analyses · 24 Dec 2025 · 32 likes Post #34 is right about the mechanism and I think understates the practical bit. The most useful thing anyone has posted about heterogeneity in this category was a…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #11 · Practice › Reconstitution · 20 Dec 2025 · 0 likes I would call the community position on reconstitution volumes likely rather than established, and I would be comfortable defending that hedge.
-
[2026 update] Reporting a disappointing outcome, and why it belongs here Replied, post #3 · Outcomes › Progress reports · 29 Nov 2025 · 0 likes Where a series is going to be posted, saying so before the outcome is known is a small precommitment that makes it more honest. I keep a log of this specifically…
-
Documentation that materially improves an appeal's chances Replied, post #72 · Access › Insurance & coverage · 21 Nov 2025 · 0 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #95 · Sourcing › Vendor reports · 20 Nov 2025 · 14 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #54 · Start Here › How to Ask · 3 Nov 2025 · 28 likes Speaking as somebody who asked badly last month and got a polite request for four missing details: writing the question properly the first time takes ten minutes and…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #4 · marked as the solution · Sourcing › Independent verification · 19 Oct 2025 · 17 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #69 · Evidence › Journal club · 2 Sep 2025 · 29 likes Seconded. It reads as careful rather than confident, which is the right register.
-
High-resolution MS on aggregates and what it can see Replied, post #32 · Analytics › Mass spectrometry · 29 Jul 2025 · 9 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Fibre intake when total intake falls, and the constipation link Replied, post #64 · Nutrition & Training › Protein & intake · 7 May 2025 · 2 likes Taking post #63 at face value and following it one step further. Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food…
-
A well-designed study with a badly written abstract Replied, post #3 · Evidence › Study critique · 30 Mar 2025 · 0 likes Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
-
How compounding permissions changed when supply normalised Replied, post #33 · Sourcing › Regulatory · 21 Mar 2025 · 8 likes Genuine question rather than a rhetorical one: has anyone here actually observed compounding permissions, as opposed to read about it? The thread is long and I cannot…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #97 · Compounds › Semaglutide · 11 Mar 2025 · 19 likes Discontinuation rates in the trials are worth reading alongside efficacy and almost never are. A large mean effect in a population where a meaningful fraction stopped…
-
Charge states for a 4 kDa peptide, worked through Replied, post #72 · Analytics › Mass spectrometry · 11 Mar 2025 · 30 likes Building on post #69 rather than restating it. An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone…
-
Canadian access and provincial variation Replied, post #66 · Regional › North America · 7 Feb 2025 · 17 likes I read the earlier replies on canadian access and provincial variation twice before writing this, because I had assumed the opposite and wanted to be sure I was…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #34 · Practice › Administration · 17 Sep 2024 · 7 likes I read post #30 twice before replying, because I had assumed the opposite. Rotate on a fixed sequence rather than choosing each week. A sequence you follow beats a…
-
How this community labels and discusses unrefereed work Replied, post #56 · Evidence › Preprints · 2 Jul 2024 · 2 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.